MARKET INSIGHTS

ZTOX Insights

AI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.

8 articles published

SHILPAMED
SHILPAMED
1 min read
Market Updates Corporate announcement

Shilpa Medicare (SHILPAMED): Company Update

Company Update Shilpa Biocare Private Limited, a wholly owned Subsidiary of Shilpa Medicare Limited, intends to make a strategic equity partnership in Gate2Brain. Shilpa Biocare Private Limited, a wholly owned Subsidiary of Shilpa Medicare Limited, intends to make a strategic equity partnership in Gate2Brain.

Read article
SHILPAMED
SHILPAMED
1 min read
Market Updates Corporate announcement

Shilpa Medicare (SHILPAMED): Company Update

Company Update Shilpa Biocare Private Limited, a wholly owned Subsidiary of Shilpa Medicare Limited, intends to make a strategic equity partnership in Gate2Brain. Shilpa Biocare Private Limited, a wholly owned Subsidiary of Shilpa Medicare Limited, intends to make a strategic equity partnership in Gate2Brain.

Read article
SHILPAMED
SHILPAMED
1 min read
Market Updates Corporate announcement

Shilpa Medicare (SHILPAMED): Press Release

Press Release Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy". Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Par

Read article
SHILPAMED
SHILPAMED
1 min read
Market Updates Corporate announcement

Shilpa Medicare (SHILPAMED): Press Release

Press Release Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy". Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Par

Read article
SHILPAMED
SHILPAMED
1 min read
Market Updates Corporate announcement

Shilpa Medicare (SHILPAMED): Company Update

Company Update USFDA Inspection of Shilpa Medicare Limited at Unit VI, Dabaspet, Bengaluru USFDA Inspection of Shilpa Medicare Limited at Unit VI, Dabaspet, Bengaluru

Read article
SHILPAMED
SHILPAMED
1 min read
Market Updates Corporate announcement

Shilpa Medicare (SHILPAMED): Company Update

Company Update USFDA Inspection of Shilpa Medicare Limited at Unit VI, Dabaspet, Bengaluru USFDA Inspection of Shilpa Medicare Limited at Unit VI, Dabaspet, Bengaluru

Read article
SHILPAMED
SHILPAMED
1 min read
Market Updates Corporate announcement

Shilpa Medicare (SHILPAMED): General Updates

General Updates Shilpa Medicare Limited has informed the Exchange about USFDA Inspection at Unit VI, Dabaspet, Bengaluru Shilpa Medicare Limited has informed the Exchange about USFDA Inspection at Unit VI, Dabaspet, Bengaluru

Read article
SHILPAMED
SHILPAMED
1 min read
Market Updates Corporate announcement

Shilpa Medicare (SHILPAMED): General Updates

General Updates Shilpa Medicare Limited has informed the Exchange about USFDA Inspection at Unit VI, Dabaspet, Bengaluru Shilpa Medicare Limited has informed the Exchange about USFDA Inspection at Unit VI, Dabaspet, Bengaluru

Read article

Live Updates

Quick Notification

AI Insights

Smart analysis of market trends

Smart Alerts

Notifications on crucial events

WhatsApp & Telegram

Alerts in the chat you already use

FREE PLAN · PAID UPGRADES FROM ₹89/MO

Track Indian stocks with ZTOX AI

NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.

Free 5 companies
Basic 20 companies
Pro Up to 500 companies
A

"ZTOX has transformed how I track companies. The real-time alerts and AI insights save me hours of research every day."

— Aditya M., Active Trader